Literature DB >> 17075726

Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.

Juan C Reyes1, Héctor M Colón, Rafael R Robles, Eddy Rios, Tomás D Matos, Juan Negrón, Carmen Amalia Marrero, José M Calderón, Elizabeth Shepard.   

Abstract

Throughout the world, injection drug users (IDUs) are the group at highest risk for hepatitis C virus (HCV) infection. IDUs residing in the island of Puerto Rico and Puerto Rican IDUs residing in the U.S. mainland have been shown to be at very high risk of infection with HIV. However, the extent to which HCV infection has spread among IDUs in Puerto Rico is not yet known. The aims of this study were to estimate seroprevalence of HCV and to identify the correlates associated with HCV transmission. The sample was drawn through street outreach strategies and was comprised of 400 injection drug users not in treatment, living in the San Juan metropolitan area. HCV and HIV infection were detected by enzyme-linked immunosorbent assay and the results were confirmed by Western blot. Information on sociodemographics, drug use patterns, and risk behaviors was obtained through structured interviews. Bivariate analyses and multivariate logistic regression were used to assess covariates of infection with HCV. The prevalence of HCV infection was 89%. After controlling for sociodemographic characteristics, HCV infection was positively associated with increasing years of injection, injecting in a shooting gallery, tattooing in prison, and self-reported STD infection. Notably, IDUs who had initiated drug injection within the year prior to the study interview had an HCV infection rate of 57%. This study indicates that more aggressive educational programs are urgently needed to reduce the spread of HCV infection among IDUs in Puerto Rico.

Entities:  

Mesh:

Year:  2006        PMID: 17075726      PMCID: PMC3261284          DOI: 10.1007/s11524-006-9109-7

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  39 in total

1.  Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999.

Authors:  S Deren; R Robles; J Andia; H M Colón; S Y Kang; T Perlis
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

2.  The social context of HIV risk behaviour by drug injectors in Ho Chi Minh City, Vietnam.

Authors:  N T Hien; L T Giang; P N Binh; I Wolffers
Journal:  AIDS Care       Date:  2000-08

3.  Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico.

Authors:  H M Colón; R R Robles; S Deren; H Sahai; H A Finlinson; J Andía; M A Cruz; S Y Kang; D Oliver-Vélez
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-01       Impact factor: 3.731

4.  Injecting shared drugs: an observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users.

Authors:  H Ann Finlinson; Héctor M Colón; Mayra Soto López; Rafaela R Robles; John G H Cant
Journal:  J Psychoactive Drugs       Date:  2005-03

5.  Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Authors:  J A Hahn; K Page-Shafer; P J Lum; K Ochoa; A R Moss
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 6.  Hepatitis C virus infection in Western Europe.

Authors:  C Trépo; P Pradat
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

7.  Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.

Authors:  S A Strathdee; N Galai; M Safaiean; D D Celentano; D Vlahov; L Johnson; K E Nelson
Journal:  Arch Intern Med       Date:  2001-05-28

8.  HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea.

Authors:  A T Entz; V P Ruffolo; V Chinveschakitvanich; V Soskolne; G J van Griensven
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

9.  Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.

Authors:  T Diaz; D C Des Jarlais; D Vlahov; T E Perlis; V Edwards; S R Friedman; R Rockwell; D Hoover; I T Williams; E R Monterroso
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

10.  Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999.

Authors:  L E Thorpe; L J Ouellet; J R Levy; I T Williams; E R Monterroso
Journal:  J Infect Dis       Date:  2000-11-02       Impact factor: 5.226

View more
  16 in total

1.  Deren et al. Respond.

Authors:  Sherry Deren; Camila Gelpí-Acosta; Carmen E Albizu-García; Angel González; Don C Des Jarlais; Salvador Santiago-Negrón
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  The law (and politics) of safe injection facilities in the United States.

Authors:  Leo Beletsky; Corey S Davis; Evan Anderson; Scott Burris
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

3.  Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City.

Authors:  Camila Gelpí-Acosta; Enrique R Pouget; Kathleen H Reilly; Holly Hagan; Alan Neaigus; Travis Wendel; David M Marshall
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

4.  Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.

Authors:  Patrick Habecker; Roberto Abadie; Melissa Welch-Lazoritz; Juan Carlos Reyes; Bilal Khan; Kirk Dombrowski
Journal:  Subst Use Misuse       Date:  2017-11-22       Impact factor: 2.164

5.  "Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implications.

Authors:  Roberto Abadie; Brandon Brown; Celia B Fisher
Journal:  Ethics Behav       Date:  2018-11-05

6.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

7.  Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico.

Authors:  Cynthia M Pérez; Edmir Marrero; Marytere Meléndez; Sandra Adrovet; Héctor Colón; Ana P Ortiz; Marievelisse Soto-Salgado; Carmen Albizu; Esther A Torres; Erick Suárez
Journal:  BMC Infect Dis       Date:  2010-03-23       Impact factor: 3.090

8.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

9.  Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling.

Authors:  David Toro-Tobón; Dedsy Berbesi-Fernandez; Pedro Mateu-Gelabert; Ángela M Segura-Cardona; Liliana P Montoya-Vélez
Journal:  Int J Drug Policy       Date:  2018-08-11

10.  Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.

Authors:  Masoumeh Amin-Esmaeili; Afarin Rahimi-Movaghar; Emran M Razaghi; Ahmad Reza Baghestani; Siavash Jafari
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.